Spots Global Cancer Trial Database for adverse event
Every month we try and update this database with for adverse event cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT) | NCT04716075 | Chronic Lymphoc... Chronic Graft-v... Mantle Cell Lym... Adverse Event Response Rate | Acalabrutinib 2... | 18 Years - 80 Years | Polish Lymphoma Research Group | |
| Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma | NCT05351931 | Anal Cancer | Salovum and SPC... | 18 Years - | Uppsala University Hospital | |
| Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial | NCT02996201 | Adverse Event Cancer, Breast Chemotherapeuti... Patient Outcome... | Completion of P... | 18 Years - | Rigshospitalet, Denmark | |
| Cancer Patients Treated With Immunotherapy in Intensive Care Unit | NCT03357861 | Cancer Critical Illnes... Immunotherapy | 18 Years - | University Hospital, Grenoble | ||
| Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments | NCT05443217 | Liver Cancer Microbiota Adverse Event Prognosis Efficacy | questionnaire s... | 18 Years - 80 Years | First Affiliated Hospital of Wenzhou Medical University | |
| Improving Care Pathway Using Simplified Digital Tools for Oncology Patients: a Multicenter "Before-and-after" Study | NCT05968027 | Oncology Adverse Event Numeric Applica... Care Telemonito... Compliance, Tre... Patient Reporte... | Nouveal numeric... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial | NCT02996201 | Adverse Event Cancer, Breast Chemotherapeuti... Patient Outcome... | Completion of P... | 18 Years - | Rigshospitalet, Denmark | |
| Electronic Patient Self-Reported Outcomes to Improve Cancer Management and Patient Experiences | NCT02847715 | Cancer | ePRIME | 18 Years - | University of Leeds | |
| 18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography | NCT04615156 | Solitary Pulmon... Oncology 18F-2-fluoro-2-... Adverse Event | 18F-2-fluoro-2-... | - | Eastern Health, Canada | |
| Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors | NCT04126590 | Advanced Solid ... | KN044 | 18 Years - 75 Years | Changchun Intellicrown Pharmaceutical Co. LTD | |
| An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy | NCT05258461 | Breast Cancer | use of a smartp... conventional ad... | 18 Years - | Peking Union Medical College Hospital | |
| Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia | NCT06082804 | Chronic Myeloge... | APN and medical... Medical managem... Quality of life... Treatment compl... | 18 Years - | Centre Hospitalier Henri Duffaut - Avignon | |
| An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy | NCT05258461 | Breast Cancer | use of a smartp... conventional ad... | 18 Years - | Peking Union Medical College Hospital | |
| Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia | NCT06082804 | Chronic Myeloge... | APN and medical... Medical managem... Quality of life... Treatment compl... | 18 Years - | Centre Hospitalier Henri Duffaut - Avignon | |
| Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia | NCT06082804 | Chronic Myeloge... | APN and medical... Medical managem... Quality of life... Treatment compl... | 18 Years - | Centre Hospitalier Henri Duffaut - Avignon | |
| An EORTC Study Updating the QLQ-BR23 to BR45 | NCT04270123 | Cancer Breast Cancer | EORTC QLQ-BR45 ... | 18 Years - | University of Leeds | |
| a Single-arm, Single-center, Open Clinical Study | NCT06431100 | Gastric Cancer Esophageal Canc... Cervical Cancer Non-Small Cell ... Triple Negative... | TCR T-cells | 18 Years - 75 Years | Beijing Geekgene Technology Co., LTD | |
| Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors | NCT04126590 | Advanced Solid ... | KN044 | 18 Years - 75 Years | Changchun Intellicrown Pharmaceutical Co. LTD | |
| Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment - a Collaborative Observational Research Project | NCT06352710 | Disc Disease Instabilities L... Brain Tumor Aneurysm | OP-Tracker App | 18 Years - | Cantonal Hospital of St. Gallen | |
| Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial | NCT02996201 | Adverse Event Cancer, Breast Chemotherapeuti... Patient Outcome... | Completion of P... | 18 Years - | Rigshospitalet, Denmark | |
| ePRIME: Patient-Reported AEs in Early Phase Trials | NCT03461939 | Cancer | ePRIME symptom ... | 18 Years - | University of Leeds | |
| Electronic Patient Self-Reported Outcomes to Improve Cancer Management and Patient Experiences | NCT02847715 | Cancer | ePRIME | 18 Years - | University of Leeds | |
| ePRIME: Patient-Reported AEs in Early Phase Trials | NCT03461939 | Cancer | ePRIME symptom ... | 18 Years - | University of Leeds | |
| Cancer Patients Treated With Immunotherapy in Intensive Care Unit | NCT03357861 | Cancer Critical Illnes... Immunotherapy | 18 Years - | University Hospital, Grenoble | ||
| High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy | NCT06063941 | Esophageal Squa... | 1% Lugol's iodi... 5% Lugol's iodi... | 18 Years - | Xijing Hospital of Digestive Diseases | |
| Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT) | NCT04716075 | Chronic Lymphoc... Chronic Graft-v... Mantle Cell Lym... Adverse Event Response Rate | Acalabrutinib 2... | 18 Years - 80 Years | Polish Lymphoma Research Group | |
| An EORTC Study Updating the QLQ-BR23 to BR45 | NCT04270123 | Cancer Breast Cancer | EORTC QLQ-BR45 ... | 18 Years - | University of Leeds | |
| The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy | NCT04764643 | Esophageal Squa... | N-acetylcystein... sodium thiosulf... | 18 Years - 80 Years | Xijing Hospital of Digestive Diseases | |
| High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy | NCT06063941 | Esophageal Squa... | 1% Lugol's iodi... 5% Lugol's iodi... | 18 Years - | Xijing Hospital of Digestive Diseases | |
| Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia | NCT06082804 | Chronic Myeloge... | APN and medical... Medical managem... Quality of life... Treatment compl... | 18 Years - | Centre Hospitalier Henri Duffaut - Avignon | |
| The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy | NCT04764643 | Esophageal Squa... | N-acetylcystein... sodium thiosulf... | 18 Years - 80 Years | Xijing Hospital of Digestive Diseases | |
| Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin | NCT03668639 | Chemotherapy-in... Adverse Event Cervical Cancer | Akynzeo Dexamethasone | 18 Years - | Odense University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
